Image_7_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... by Zachary D. Wallen (19986522)

“…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”

Table_1_Assessing the Relationship Between Leukocyte Telomere Length and Cancer Risk/Mortality in UK Biobank and TCGA Datasets With the Genetic Risk Score and Mendelian Randomizati... by Yixin Gao (3182019)

“…</p>Results<p>In the UK Biobank dataset, we found that the GRS of leukocyte telomere length was associated with a decreased risk of nine types of cancer (i.e., significant association with multiple myeloma, chronic lymphocytic leukemia, kidney/renal cell cancer, bladder cancer, malignant melanoma, basal cell carcinoma, and prostate cancer and suggestive association with sarcoma/fibrosarcoma and Hodgkin’s lymphoma/Hodgkin’s disease). …”

Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

“…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”

Table_1_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.docx by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

“…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”

Table_3_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.xlsx by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Table_2_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.xlsx by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

“…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”

Image_8_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Image_4_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Table_4_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.xlsx by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Image_15_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Image_12_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Image_1_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

“…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”

Image_11_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Image_9_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Image_2_Strain level and comprehensive microbiome analysis in inflammatory bowel disease via multi-technology meta-analysis identifies key bacterial influencers of disease.TIFF by Jayamary Divya Ravichandar (13957323)

“…Objective<p>Inflammatory bowel disease (IBD) is a heterogenous disease in which the microbiome has been shown to play an important role. …”

Table_1_Sirt1 Promotes the Restoration of Hepatic Progenitor Cell (HPC)-Mediated Liver Fatty Injury in NAFLD Through Activating the Wnt/β-Catenin Signal Pathway.DOCX by Qinjin Li (11838788)

“…Glycogen PAS staining demonstrated that Sirt1 OE promoted WB-F344 cells to differentiate into mature hepatocytes with glycogen synthesis ability, while Sirt1 inhibitor EX527 or Wnt/β-catenin pathway inhibitor HF535 decreased glycogen positive cells. Together, our data suggested that Sirt1 plays a vital role in activating HPCs to repair fatty liver injury or promote liver regeneration through the Wnt/β-catenin signal pathway in NAFLD, which might provide a new strategy for fatty liver injury or NAFLD therapy.…”